Background: Patients with non-small cell lung cancer (NSCLC) with PD-L1 expression
- Svaton, M.
- Knetki-Wroblewska, M.
- Hosek, P.
- Chowaniecova, G.
- Spacek, J.
- Fischer, O.
- Bilek, O.
- Hrnciarik, M.
- Kauffmann-Guerrero, D.
Keywords
- Nsclc
- chemotherapy
- high PD-L1 expression
- immunochemotherapy, pembrolizumab
- real-world evidence
